Company Dr. Martens plc

Equities

DOCS

GB00BL6NGV24

Footwear

Market Closed - London S.E. 16:35:07 17/05/2024 BST 5-day change 1st Jan Change
85 GBX +2.60% Intraday chart for Dr. Martens plc +7.26% -4.06%

Business Summary

Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA); Americas; and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels, and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion, and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.

Number of employees: 2,591

Sales per Business

GBP in Million2022Weight2023Weight Delta
Wholesale
47.9 %
460 50.7 % 480 47.9 % +4.19%
Ecommerce
27.9 %
262 28.9 % 279 27.9 % +6.33%
Retail
24.2 %
186 20.4 % 242 24.2 % +30.23%

Sales per region

GBP in Million2022Weight2023Weight Delta
EMEA
44.3 %
399 43.9 % 443 44.3 % +11.17%
America
42.8 %
383 42.1 % 428 42.8 % +11.89%
APAC
12.9 %
127 14.0 % 129 12.9 % +1.57%

Managers

Managers TitleAgeSince
Chief Executive Officer 57 30/06/18
Chief Tech/Sci/R&D Officer 54 31/03/20
Chief Operating Officer 58 31/05/18
Investor Relations Contact - 31/01/21
Sales & Marketing - 31/03/22
Corporate Officer/Principal 45 31/03/17
Corporate Officer/Principal 46 31/03/18
Corporate Officer/Principal 50 31/08/19
Corporate Officer/Principal 53 31/12/20
Human Resources Officer 49 31/03/15

Members of the board

Members of the board TitleAgeSince
Chairman 64 31/08/15
Director/Board Member 51 31/12/20
Director/Board Member 54 30/04/23
Chief Executive Officer 57 30/06/18
Director/Board Member 50 31/12/20
Director/Board Member 42 30/04/15
Director/Board Member 57 31/12/20
Corporate Officer/Principal 53 31/12/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 961,935,832 565,378,303 ( 58.78 %) 0 58.78 %

Shareholders

NameEquities%Valuation
Permira Advisers LLP
38.46 %
369,942,440 38.46 % 352 M p
HSBC Private Bank (UK) Ltd.
5.830 %
56,081,000 5.830 % 53 M p
Artemis Investment Management LLP
5.291 %
50,888,425 5.291 % 48 M p
GIC Pte Ltd. (Investment Management)
5.203 %
50,042,193 5.203 % 48 M p
BlackRock Investment Management (UK) Ltd.
4.167 %
40,081,203 4.167 % 38 M p
Royal London Asset Management Ltd.
3.823 %
36,773,000 3.823 % 35 M p
FIL Investment Advisors (UK) Ltd.
3.138 %
30,187,000 3.138 % 29 M p
The Vanguard Group, Inc.
2.072 %
19,931,173 2.072 % 19 M p
Jupiter Asset Management Ltd.
1.521 %
14,628,241 1.521 % 14 M p
Norges Bank Investment Management
1.365 %
13,128,000 1.365 % 12 M p

Company contact information

Dr. Martens Plc

28 Jamestown Road Camden

NW1 7BY, London

+44 12 1415 7047

http://www.drmartensplc.com
address Dr. Martens plc(DOCS)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
0.85 GBP
Average target price
0.7302 GBP
Spread / Average Target
-14.09%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DOCS Stock
  4. Company Dr. Martens plc